cognitive cybersecurity intelligence

News and Analysis

Digital Tech as a CDMO Differentiator

Demand for access to real-time production data is promoting the adoption of digital bioprocessing technology in the pharmaceutical subcontracting sector, particularly by contract development and manufacturing organisations (CDMOs), says Rob Perry, senior director of manufacturing engineering for Thermo Fisher’s Pharma Services sector. Benefits include reduced paperwork, productivity improvements, increased manufacturing visibility and capacity expansion. Regulators, though working to keep pace with technological developments, present a challenge. Staff training on augmented and virtual reality tools and facilities’ virtual tours are also proving cost-effective.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts